Microba Intangible Assets vs Accounts Payable Analysis

MAP Stock   0.19  0.01  5.56%   
Microba Life financial indicator trend analysis is infinitely more than just investigating Microba Life Sciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Microba Life Sciences is a good investment. Please check the relationship between Microba Life Intangible Assets and its Accounts Payable accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microba Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Intangible Assets vs Accounts Payable

Intangible Assets vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Microba Life Sciences Intangible Assets account and Accounts Payable. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Microba Life's Intangible Assets and Accounts Payable is 0.92. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Microba Life Sciences, assuming nothing else is changed. The correlation between historical values of Microba Life's Intangible Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of Microba Life Sciences are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Intangible Assets i.e., Microba Life's Intangible Assets and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.92
Relationship DirectionPositive 
Relationship StrengthVery Strong

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Accounts Payable

An accounting item on the balance sheet that represents Microba Life obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Microba Life Sciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Microba Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Microba Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microba Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Microba Life's Selling General Administrative is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 19.6 M in 2024, whereas Tax Provision is likely to drop 4,690 in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense8.3K60.4K69.2K40.8K
Depreciation And Amortization1.5M1.6M2.9M1.7M

Microba Life fundamental ratios Correlations

0.960.840.870.990.950.83-0.85-0.920.860.860.70.620.860.910.850.210.680.740.730.840.940.980.731.00.94
0.960.760.840.950.980.89-0.81-0.870.80.830.680.60.830.870.790.430.680.70.550.810.890.980.70.950.99
0.840.760.980.80.780.68-0.62-0.970.990.630.90.850.630.960.91-0.10.870.940.790.970.740.830.930.860.68
0.870.840.980.840.840.79-0.67-0.990.970.680.920.870.680.970.890.060.90.950.710.990.780.880.940.890.77
0.990.950.80.840.920.82-0.91-0.890.840.920.640.550.920.90.790.260.620.680.720.80.970.960.680.980.94
0.950.980.780.840.920.81-0.71-0.870.820.730.760.70.730.870.880.390.760.760.510.840.820.960.770.930.96
0.830.890.680.790.820.81-0.76-0.830.660.770.590.520.770.750.610.30.590.650.520.750.820.90.60.850.83
-0.85-0.81-0.62-0.67-0.91-0.71-0.760.73-0.66-1.0-0.39-0.27-1.0-0.77-0.47-0.36-0.36-0.43-0.65-0.6-0.98-0.82-0.42-0.82-0.84
-0.92-0.87-0.97-0.99-0.89-0.87-0.830.73-0.96-0.74-0.88-0.82-0.74-0.98-0.89-0.07-0.86-0.92-0.75-0.98-0.84-0.92-0.9-0.93-0.81
0.860.80.990.970.840.820.66-0.66-0.960.670.90.840.670.990.910.020.870.920.750.960.770.850.920.880.75
0.860.830.630.680.920.730.77-1.0-0.740.670.40.291.00.780.490.370.380.440.650.610.980.840.440.840.86
0.70.680.90.920.640.760.59-0.39-0.880.90.40.990.40.850.90.051.00.990.480.960.520.71.00.720.61
0.620.60.850.870.550.70.52-0.27-0.820.840.290.990.290.780.870.020.990.980.40.920.410.620.980.640.52
0.860.830.630.680.920.730.77-1.0-0.740.671.00.40.290.780.490.370.380.440.650.610.980.840.440.840.86
0.910.870.960.970.90.870.75-0.77-0.980.990.780.850.780.780.870.130.830.880.750.950.860.910.880.920.83
0.850.790.910.890.790.880.61-0.47-0.890.910.490.90.870.490.87-0.030.880.90.650.910.640.830.910.860.73
0.210.43-0.10.060.260.390.3-0.36-0.070.020.370.050.020.370.13-0.030.1-0.03-0.430.070.270.260.040.140.52
0.680.680.870.90.620.760.59-0.36-0.860.870.381.00.990.380.830.880.10.980.410.950.490.680.990.690.6
0.740.70.940.950.680.760.65-0.43-0.920.920.440.990.980.440.880.9-0.030.980.580.980.570.740.990.760.61
0.730.550.790.710.720.510.52-0.65-0.750.750.650.480.40.650.750.65-0.430.410.580.640.740.680.520.770.49
0.840.810.970.990.80.840.75-0.6-0.980.960.610.960.920.610.950.910.070.950.980.640.720.840.970.860.74
0.940.890.740.780.970.820.82-0.98-0.840.770.980.520.410.980.860.640.270.490.570.740.720.920.560.920.9
0.980.980.830.880.960.960.9-0.82-0.920.850.840.70.620.840.910.830.260.680.740.680.840.920.720.980.95
0.730.70.930.940.680.770.6-0.42-0.90.920.441.00.980.440.880.910.040.990.990.520.970.560.720.750.63
1.00.950.860.890.980.930.85-0.82-0.930.880.840.720.640.840.920.860.140.690.760.770.860.920.980.750.91
0.940.990.680.770.940.960.83-0.84-0.810.750.860.610.520.860.830.730.520.60.610.490.740.90.950.630.91
Click cells to compare fundamentals

Microba Life Account Relationship Matchups

Microba Life fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets10.8M18.5M39.5M47.0M58.0M34.4M
Short Long Term Debt Total563.6K269.0K1.3M1.1M1.6M968.7K
Other Current Liab988.1K1.7M1.1M3.9M5.3M5.5M
Total Current Liabilities2.8M3.4M5.3M7.8M12.4M13.0M
Total Stockholder Equity7.7M14.9M33.5M38.6M41.2M27.2M
Property Plant And Equipment Net1.6M1.2M2.8M2.6M3.9M2.5M
Current Deferred Revenue1.1M1.1M2.6M1.3M2.2M1.6M
Net Debt(6.3M)(12.8M)(29.3M)(30.9M)(19.3M)(20.3M)
Retained Earnings(12.2M)(19.7M)(31.2M)(43.9M)(63.8M)(60.6M)
Accounts Payable392.3K353.5K813.2K3.0M3.7M3.9M
Cash6.9M13.0M30.6M32.0M20.9M21.0M
Non Current Assets Total2.7M2.3M3.7M5.4M25.8M27.1M
Cash And Short Term Investments6.9M13.0M30.6M32.0M20.9M21.0M
Net Receivables622.8K376.3K3.4M7.2M8.1M8.5M
Long Term Debt Total245.4K66.8K483.8K234.1K269.2K287.6K
Liabilities And Stockholders Equity10.8M18.5M39.5M47.0M58.0M34.4M
Non Current Liabilities Total260.6K110.4K678.6K404.1K4.5M4.7M
Inventory340.8K513.3K360.0K644.4K2.2M2.4M
Other Current Assets244.6K1.0M204.4K1.6M1.0M781.9K
Other Stockholder Equity622.9K1.2M78.2K2.1M2.4M2.5M
Total Liab3.1M3.5M5.9M8.2M16.8M17.7M
Total Current Assets8.1M16.2M35.8M41.5M32.2M26.7M
Accumulated Other Comprehensive Income622.9K1.2M1.9M2.1M2.2M1.5M
Cash And Equivalents49.8K50.3K204.4K12.4M14.3M15.0M
Short Term Debt318.2K202.3K841.4K901.7K1.2M660.2K
Intangible Assets118.7K246.3K853.9K2.8M13.4M14.1M
Common Stock19.3M33.5M62.9M80.4M102.9M58.1M
Property Plant Equipment1.6M1.2M2.8M2.6M3.0M2.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Microba Stock Analysis

When running Microba Life's price analysis, check to measure Microba Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microba Life is operating at the current time. Most of Microba Life's value examination focuses on studying past and present price action to predict the probability of Microba Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microba Life's price. Additionally, you may evaluate how the addition of Microba Life to your portfolios can decrease your overall portfolio volatility.